Human Insulin Drugs & Delivery Devices Market size will exceed U - Erie News Now | WICU & WSEE in Erie, PA

Human Insulin Drugs & Delivery Devices Market size will exceed US$ 45 Billion by 2022


New York, August 31, 2017 /Financeswire/: Market Research Engine has published a new report titled as “Human Insulin Drugs & Delivery Devices Market By Product Analysis (HI Drugs, HI Delivery Devices); By Drug Analysis (Insulin Analogs & Biosimilars, HI Biologics); By Delivery Devices Analysis (Syringes, Pens, and Pen Needles) and by regional analysis – global forecast by 2016 – 2022”.

The Global Human Insulin Drugs & Delivery Devices Market is expected to exceed more than US$ 45.36 Billion by 2022 at a CAGR of 8.00% in the given forecast period.

The major driving factors of Global Human Insulin Drugs & Delivery Devices Market As follows:

  • Increase in Diabetic patient population
  • Rising market demand for Insulin drugs
  • Technological advancement of Insulin drugs
  • Proper reimbursement policy in developed countries

The restraining factors of Global Insulin Drugs & Delivery Devices Market as follows:

  • High Manufacturing cost
  • Increase in the population exposure
  • Stringent regulatory reforms for product sanction

You can browse full report here:

This report provides:

1) An overview of the global market for Insulin Drugs & Delivery Devices.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022
3) Identifications of new market opportunities and targeted promotional plans for Global Insulin Drugs & Delivery Devices Market
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Report scope:

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Eli Lilly and Company (U.S.), Biocon Ltd. (India), Julphar (U.A.E.), Sanofi (France), Ypsomed AG (Switzerland), Becton, Dickinson and Company (U.S.), Wockhardt Ltd. (India). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.


Table of Contents


2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global Human Insulin Market, By Product Type

8 Global Human Insulin Drugs Market, By Type

9 Global Human Insulin Drugs Market, By Brand

10 Global Human Insulin Market, By Delivery Devices

11 Global Human Insulin Market, By Application

12 Human Insulin Market, By Region

13 Competitive Landscape

14 Company Profiles

14.1 Introduction

14.2 B. Braun Melsungen AG

14.3 Becton, Dickinson and Company

14.4 Biocon Limited

14.5 Biodel Inc.

14.6 ELI Lilly and Company

14.7 Julphar

14.8 NOVO Nordisk A/S

14.9 Sanofi

14.10 Wockhardt Limited

14.11 Ypsomed AG


Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States




Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 -